Corporate history

Established in January 1999, braute is a state-level high-tech enterprise focusing on R & D, manufacturing and sales of in vitro diagnostic reagents.

Personalized precision therapy

The products include precise diagnosis of infectious diseases, autoimmune diseases, endocrine diseases, neuroimmune diseases and tumor prevention and control. They are committed to providing all-round, high-quality diagnostic products and medical testing services.。

Strong technology accumulation

The company has rich technical reserves and won the second prize of the national science and technology progress award. It has the industry-leading typing and detection technology of Helicobacter pylori. Its raw material production platform adopts the international advanced single B cell method to cultivate antibodies, and has a number of invention and creation patents.

Broad customer resources

The company's market radiates all major cities in China, and its customers cover all kinds of hospitals, scientific research institutions, professional physical examination institutions and third-party testing institutions. It has established cooperative relations with Peking University Hospital, Peking Union Medical College Hospital, Jinyu testing and other well-known medical institutions, and its unique characteristics have been unanimously recognized by users.

Perfect equipment environment

The company has 10000 grade and 100000 grade GMP purification workshops, 6 specialized laboratories, multiple cold stores and professional cold chain logistics system. The designed production capacity is 5 million person / year. At present, the construction of production site is being expanded, and the planned production capacity is expanded to 50 million person / year.

Construction and improvement of technology platform

Relying on the existing reagent products, the company expands the upstream industrial chain and establishes a raw material production platform. The cooperation of the two platforms, namely the biological detection technology platform and the raw material production platform, will help the company increase the variety of various biological detection reagents and optimize the upstream and downstream industrial chain.

Sustainable development company

We took the lead in developing and producing clinical test products for the virulence typing of Helicobacter pylori, which revolutionized the level of accurate diagnosis and treatment of Helicobacter pylori related diseases, protected the health of a large number of HP infected people, and also saved a lot of valuable medical resources

>BLOT story

>Mission and strategy

>Common goals and core values